First blood-brain barrier chip using stem cells developed
Researchers have, for the first time, duplicated a patient's blood-brain barrier (BBB), creating a human BBB chip with stem cells.
List view / Grid view
Researchers have, for the first time, duplicated a patient's blood-brain barrier (BBB), creating a human BBB chip with stem cells.
13 June 2019 | By Sartorius AG
The new generation of modular premium laboratory balances.
Scientists have discovered a cell intrinsic tumour suppressor role of the innate immune sensor Toll-like receptor 2.
A new study shows promise for future neural stem cell therapies in replacing cells lost through disease or injury.
ZYNTEGLO™ is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT).
A study of almost half a million people links a mutation that protects against HIV infection to an earlier death.
In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.
A new study shows that the growth rate of a tumour does not depend solely on how quickly the cancer cells can divide.
An international team of researchers has proven that targeting a specific area of the flu virus protects humans.
Using exclusively male animals in experiments biases results, argues Rebecca Shansky.
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
Researchers succeed in using machine learning to make the mass analysis of proteins faster and almost error-free.
New research could lead to novel treatments for autoimmune disorders and sheds light on the causes of autoimmunity.
Researchers use stem cell-based disease models to pinpoint gene linked to impaired memory in Down syndrome.